Lazard Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $734K | Sell |
3,272
-6,948
| -68% | -$1.73M | ﹤0.01% | 1256 |
|
|
2025
Q4 | $2.46M | Buy |
10,220
+1,548
| +18% | +$396K | ﹤0.01% | 784 |
|
|
2025
Q3 | $2.37M | Sell |
8,672
-3,011
| -26% | -$822K | ﹤0.01% | 805 |
|
|
2025
Q2 | $3.01M | Buy |
11,683
+360
| +3% | +$85.9K | ﹤0.01% | 878 |
|
|
2025
Q1 | $2.53M | Buy |
11,323
+2,061
| +22% | +$481K | ﹤0.01% | 893 |
|
|
2024
Q4 | $2.12M | Sell |
9,262
-1,080
| -10% | -$260K | ﹤0.01% | 858 |
|
|
2024
Q3 | $2.52M | Sell |
10,342
-897
| -8% | -$200K | ﹤0.01% | 820 |
|
|
2024
Q2 | $2.15M | Buy |
11,239
+11,187
| +21,513% | +$2.27M | ﹤0.01% | 848 |
|
|
2024
Q1 | $10K | Hold |
52
| – | – | ﹤0.01% | 1871 |
|
|
2023
Q4 | $8K | Buy |
52
+1
| +2% | +$154 | ﹤0.01% | 2104 |
|
|
2023
Q3 | $7K | Sell |
51
-5,085
| -99% | -$919K | ﹤0.01% | 2166 |
|
|
2023
Q2 | $1.12M | Buy |
5,136
+1,456
| +40% | +$325K | ﹤0.01% | 971 |
|
|
2023
Q1 | $805K | Sell |
3,680
-3
| -0.1% | -$651 | ﹤0.01% | 1045 |
|
|
2022
Q4 | $766K | Sell |
3,683
-111
| -3% | -$24.4K | ﹤0.01% | 1045 |
|
|
2022
Q3 | $828K | Buy |
3,794
+40
| +1% | +$9.1K | ﹤0.01% | 1015 |
|
|
2022
Q2 | $786K | Sell |
3,754
-34,566
| -90% | -$7.36M | ﹤0.01% | 1033 |
|
|
2022
Q1 | $9.29M | Sell |
38,320
-4,345
| -10% | -$1.05M | 0.01% | 634 |
|
|
2021
Q4 | $11.1M | Sell |
42,665
-671
| -2% | -$174K | 0.01% | 606 |
|
|
2021
Q3 | $11.4M | Sell |
43,336
-6,932
| -14% | -$1.9M | 0.01% | 597 |
|
|
2021
Q2 | $12.4M | Buy |
50,268
+14,992
| +42% | +$3.15M | 0.01% | 553 |
|
|
2021
Q1 | $6.84M | Buy |
35,276
+23,355
| +196% | +$4.68M | 0.01% | 624 |
|
|
2020
Q4 | $2.53M | Buy |
11,921
+11,421
| +2,284% | +$2.28M | ﹤0.01% | 757 |
|
|
2020
Q3 | $85K | Sell |
500
-116
| -19% | -$21.4K | ﹤0.01% | 1048 |
|
|
2020
Q2 | $118K | Buy |
616
+5
| +0.8% | +$818 | ﹤0.01% | 983 |
|
|
2020
Q1 | $89K | Sell |
611
-394
| -39% | -$62.8K | ﹤0.01% | 1022 |
|
|
2019
Q4 | $155K | Buy |
1,005
+505
| +101% | +$72.8K | ﹤0.01% | 937 |
|
|
2019
Q3 | $67K | Sell |
500
-13,037
| -96% | -$1.71M | ﹤0.01% | 990 |
|
|
2019
Q2 | $1.65M | Buy |
13,537
+112
| +0.8% | +$12.4K | ﹤0.01% | 776 |
|
|
2019
Q1 | $1.4M | Buy |
+13,425
| New | +$1.39M | ﹤0.01% | 798 |
|
|
2016
Q2 | – | Sell |
-22
| Closed | -$1K | – | 1096 |
|
|
2016
Q1 | $1K | Hold |
22
| – | – | ﹤0.01% | 1021 |
|
|
2015
Q4 | $1K | Buy |
+22
| New | +$1.24K | ﹤0.01% | 1082 |
|
|
2014
Q4 | – | Sell |
-47
| Closed | -$2K | – | 1161 |
|
|
2014
Q3 | $2K | Buy |
+47
| New | +$2.39K | ﹤0.01% | 1024 |
|
|
2014
Q2 | – | Sell |
-2,507
| Closed | -$112K | – | 1050 |
|
|
2014
Q1 | $112K | Sell |
2,507
-43,074
| -94% | -$1.93M | ﹤0.01% | 864 |
|
|
2013
Q4 | $2.15M | Buy |
45,581
+17,043
| +60% | +$863K | ﹤0.01% | 623 |
|
|
2013
Q3 | $1.51M | Buy |
+28,538
| New | +$1.38M | ﹤0.01% | 636 |
|
Other funds holding RMD
VCM
VPM
DAM
Lazard Asset Management's RMD Position: Q1 2026 in Review
Lazard Asset Management reduced its ResMed (RMD) stake by 68% in Q1 2026, selling an estimated $1.73M and leaving 3,272 shares worth $734K. The position accounts for ﹤0.01% of the portfolio, ranked #1256.
Lazard Asset Management first reported a position in RMD in Q3 2013 and has held it in 35 quarters since. The position peaked at $12.4M in Q2 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Lazard Asset Management held 3,272 shares of ResMed worth $734K as of Q1 2026.
- Lazard Asset Management sold 6,948 ResMed shares in Q1 2026, an estimated $1.73M.
- ResMed made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #1256 holding.
- Lazard Asset Management first reported a position in ResMed in Q3 2013 and has held it in 35 quarters since.
- Lazard Asset Management's ResMed position peaked at $12.4M in Q2 2021.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.